• 1
    Peris-Bonet R, Martinez-Garcia C, Lacour B, et al. Childhood central nervous system tumours—incidence and survival in Europe (1978-1997): report from Automated Childhood Cancer Information System project. Eur J Cancer. 2006; 42: 2064-2080.
  • 2
    Stiller CA. Childhood Cancer in Britain: Incidence, Survival, Mortality. Oxford, UK: Oxford University Press; 2007.
  • 3
    Louis DN, Ohgaki H, Wiestler D, Cavanee WK. WHO Classification of Tumours of the Central Nervous System. Lyon, France: IARC Press; 2007.
  • 4
    Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms tumors: results from the First National Wilms' Tumor Study. Cancer. 1978; 41: 1937-1948.
  • 5
    Lynch HT, Shurin SB, Dahms BB, Izant RJJr, Lynch J, Danes BS. Paravertebral malignant rhabdoid tumor in infancy. In vitro studies of a familial tumor. Cancer. 1983; 52: 290-296.
  • 6
    Bonnin JM, Rubinstein LJ, Palmer NF, Beckwith JB. The association of embryonal tumors originating in the kidney and in the brain. A report of 7 cases. Cancer. 1984; 54: 2137-2146.
  • 7
    Rorke LB, Packer RJ, Biegel JA. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg. 1996; 85: 56-65.
  • 8
    Kleihues P, Cavanee WK. Pathology and Genetics of Tumours of the Nervous System. 3rd edition. Lyon, France: IARC Press; 2000.
  • 9
    Fritz A, Percy C, Jack A, et al. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
  • 10
    Burger PC, Yu IT, Tihan T, et al. Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study. Am J Surg Pathol. 1998; 22: 1083-1092.
  • 11
    Haberler C, Laggner U, Slavc I, et al. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Am J Surg Pathol. 2006; 30: 1462-1468.
  • 12
    Versteege I, Sevenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature. 1998; 394: 203-206.
  • 13
    Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 1999; 59: 74-79.
  • 14
    Judkins AR, Mauger J, Ht A, Rorke LB, Biegel JA. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol. 2004; 28: 644-650.
  • 15
    Rorke LB, Packer R, Biegel J. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. J Neurooncol. 1995; 24: 21-28.
  • 16
    Tekautz TM, Fuller CE, Blaney S, et al. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol. 2005; 23: 1491-1499.
  • 17
    Hilden JM, Watterson J, Longee DC, et al. Central nervous system atypical teratoid tumor/rhabdoid tumor: response to intensive therapy and review of the literature. J Neurooncol. 1998; 40: 265-275.
  • 18
    Hilden JM, Meerbaum S, Burger P, et al. Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. J Clin Oncol. 2004; 22: 2877-2884.
  • 19
    Chen YW, Wong TT, Ho DM, et al. Impact of radiotherapy for pediatric CNS atypical teratoid/rhabdoid tumor (single institute experience). Int J Radiat Oncol Biol Phys. 2006; 64: 1038-1043.
  • 20
    Gardner SL, Asgharzadeh S, Green A, Horn B, McCowage G, Finlay J. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Pediatr Blood Cancer. 2008; 51: 235-240.
  • 21
    Chi SN, Zimmerman MA, Yao X, et al. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol. 2009; 27: 385-389.
  • 22
    Arrazola J, Pedrosa I, Mendez R, Saldana C, Scheithauer BW, Martinez A. Primary malignant rhabdoid tumour of the brain in an adult. Neuroradiology. 2000; 42: 363-367.
  • 23
    Lutterbach J, Liegibel J, Koch D, Madlinger A, Frommhold H, Pagenstecher A. Atypical teratoid/rhabdoid tumors in adult patients: case report and review of the literature. J Neurooncol. 2001; 52: 49-56.
  • 24
    Pimentel J, Silva R, Pimentel T. Primary malignant rhabdoid tumors of the central nervous system: considerations about 2 cases of adulthood presentation. J Neurooncol. 2003; 61: 121-126.
  • 25
    Kawaguchi T, Kumabe T, Watanabe M, Tominaga T. Atypical teratoid/rhabdoid tumour with leptomeningeal dissemination in an adult. Acta Neurochir (Wien). 2004; 146: 1033-1038.
  • 26
    Erickson ML, Johnson R, Bannykh SI, de Lotbiniere A, Kim JH. Malignant rhabdoid tumor in a pregnant adult female: literature review of central nervous system rhabdoid tumors. J Neurooncol. 2005; 74: 311-319.
  • 27
    Raisanen J, Biegel JA, Hatanpaa KJ, Judkins A, White CL, Perry A. Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults. Brain Pathol. 2005; 15: 23-28.
  • 28
    Rezanko T, Tunakan M, Kahraman A, Sucu HK, Gelal F, Akkol I. Primary rhabdoid tumor of the brain in an adult. Neuropathology. 2006; 26: 57-61.
  • 29
    Zarovnaya EL, Pallatroni HF, Hug EB, et al. Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literature. J Neurooncol. 2007; 84: 49-55.
  • 30
    Arita K, Sugiyama K, Sano T, Oka H. Atypical teratoid/rhabdoid tumour in sella turcica in an adult. Acta Neurochir (Wien). 2008; 150: 491-496.
  • 31
    Makuria AT, Rushing EJ, McGrail KM, Hartmann DP, Azumi N, Ozdemirli M. Atypical teratoid rhabdoid tumor (AT/RT) in adults: review of 4 cases. J Neurooncol. 2008; 88: 321-330.
  • 32
    Samaras V, Stamatelli A, Samaras E, et al. Atypical teratoid/rhabdoid tumor of the central nervous system in an 18-year-old patient. Clin Neuropathol. 2009; 28: 1-10.
  • 33
    Rickert CH, Paulus W. Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification. Childs Nerv Syst. 2001; 17: 503-511.
  • 34
    Wong TT, Ho DM, Chang KP, et al. Primary pediatric brain tumors: statistics of Taipei VGH, Taiwan (1975-2004). Cancer. 2005; 104: 2156-2167.
  • 35
    Kaderali Z, Lamberti-Pasculli M, Rutka JT. The changing epidemiology of paediatric brain tumours: a review from the Hospital for Sick Children. Childs Nerv Syst. 2009; 25: 787-793.
  • 36
    Wohrer A, Waldhor T, Heinzl H, et al. The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry. J Neurooncol. 2009; 95: 401-411.
  • 37
    Hornick JL, Dal Cin P, Fletcher CD. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Am J Surg Pathol. 2009; 33: 542-550.
  • 38
    Bauchet L, Rigau V, Mathieu-Daude H, et al. Clinical epidemiology for childhood primary central nervous system tumors. J Neurooncol. 2009; 92: 87-98.
  • 39
    CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2005. Available at: html Accessed January 10, 2010.
  • 40
    Kaatsch P, Steliarova-Foucher E, Crocetti E, Magnani C, Spix C, Zambon P. Time trends of cancer incidence in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006; 42: 1961-1971.
  • 41
    Pritchard-Jones K, Kaatsch P, Steliarova-Foucher E, Stiller CA, Coebergh JW. Cancer in children and adolescents in Europe: developments over 20 years and future challenges. Eur J Cancer. 2006; 42: 2183-2190.
  • 42
    Arora RS, Alston RD, Eden TO, Estlin EJ, Moran A, Birch JM. Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England. Neuro Oncol. 2009; 11: 403-413.
  • 43
    Fruhwald MC, Hasselblatt M, Wirth S, et al. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome. Pediatr Blood Cancer. 2006; 47: 273-278.
  • 44
    Modena P, Lualdi E, Facchinetti F, et al. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res. 2005; 65: 4012-4019.
  • 45
    Hoot AC, Russo P, Judkins AR, Perlman EJ, Biegel JA. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol. 2004; 28: 1485-1491.
  • 46
    Hasegawa T, Matsuno Y, Shimoda T, Umeda T, Yokoyama R, Hirohashi S. Proximal-type epithelioid sarcoma: a clinicopathologic study of 20 cases. Mod Pathol. 2001; 14: 655-663.
  • 47
    Boyd C, Smith MJ, Kluwe L, Balogh A, Maccollin M, Plotkin SR. Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet. 2008; 74: 358-366.
  • 48
    Patil S, Perry A, Maccollin M, et al. Immunohistochemical analysis supports a role for INI1/SMARCB1 in hereditary forms of schwannomas, but not in solitary, sporadic schwannomas. Brain Pathol. 2008; 18: 517-519.
  • 49
    Hasselblatt M, Oyen F, Gesk S, et al. Cribriform neuroepithelial tumor (CRINET): a nonrhabdoid ventricular tumor with INI1 loss and relatively favorable prognosis. J Neuropathol Exp Neurol. 2009; 68: 1249-1255.
  • 50
    Slavc I, Peyrl A, Czech T, Haberler C, Dieckmann K. New treatment strategy improves survival of CNS atypical teratoid rhabdoid tumors [abstract]. Pediatr Blood Cancer. 2009; 53: 701-915. Abstract PM.035.
  • 51
    Rutkowski S, Bode U, Deinlein F, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med. 2005; 352: 978-986.
  • 52
    Fruhwald MC, Krefeld B, Benesch M, et al. The European Rhabdoid Registry (EU-RHAB)—a comprehensive approach towards biology and clinical management [abstract]. Neuro-Oncology. 2010; 16: ii36.Abstract ATRT.01.